 | • レポートコード：GIR-2104Z14841 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、フォンウィルブランド病治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。フォンウィルブランド病治療の種類別市場規模（ボンベンディ、フミン酸塩-P、アルファネート、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・フォンウィルブランド病治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Takeda、CSL Behring、Baxter、Grifols、Octapharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ボンベンディ、フミン酸塩-P、アルファネート、その他 ・用途別分析2016年-2026年：病院、診療所、その他 ・フォンウィルブランド病治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・フォンウィルブランド病治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・フォンウィルブランド病治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・フォンウィルブランド病治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・フォンウィルブランド病治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Von Willebrand Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Von Willebrand Disease Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Von Willebrand Disease Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Von Willebrand Disease Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Veyvondi
Humate-P
Alphanate
Others
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
Takeda
CSL Behring
Baxter
Grifols
Octapharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Von Willebrand Disease Treatment
1.2 Classification of Von Willebrand Disease Treatment by Type
1.2.1 Overview: Global Von Willebrand Disease Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Von Willebrand Disease Treatment Revenue Market Share by Type in 2020
1.2.3 Veyvondi
1.2.4 Humate-P
1.2.5 Alphanate
1.2.6 Others
1.3 Global Von Willebrand Disease Treatment Market by Application
1.3.1 Overview: Global Von Willebrand Disease Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Von Willebrand Disease Treatment Market Size & Forecast
1.5 Global Von Willebrand Disease Treatment Market Size and Forecast by Region
1.5.1 Global Von Willebrand Disease Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Von Willebrand Disease Treatment Market Size by Region, (2016-2021)
1.5.3 North America Von Willebrand Disease Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Von Willebrand Disease Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Von Willebrand Disease Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Von Willebrand Disease Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Von Willebrand Disease Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Von Willebrand Disease Treatment Market Drivers
1.6.2 Von Willebrand Disease Treatment Market Restraints
1.6.3 Von Willebrand Disease Treatment Trends Analysis
2 Company Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Von Willebrand Disease Treatment Product and Solutions
2.1.4 Takeda Von Willebrand Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Takeda Recent Developments and Future Plans
2.2 CSL Behring
2.2.1 CSL Behring Details
2.2.2 CSL Behring Major Business
2.2.3 CSL Behring Von Willebrand Disease Treatment Product and Solutions
2.2.4 CSL Behring Von Willebrand Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 CSL Behring Recent Developments and Future Plans
2.3 Baxter
2.3.1 Baxter Details
2.3.2 Baxter Major Business
2.3.3 Baxter Von Willebrand Disease Treatment Product and Solutions
2.3.4 Baxter Von Willebrand Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Baxter Recent Developments and Future Plans
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Von Willebrand Disease Treatment Product and Solutions
2.4.4 Grifols Von Willebrand Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Grifols Recent Developments and Future Plans
2.5 Octapharma
2.5.1 Octapharma Details
2.5.2 Octapharma Major Business
2.5.3 Octapharma Von Willebrand Disease Treatment Product and Solutions
2.5.4 Octapharma Von Willebrand Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Octapharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Von Willebrand Disease Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Von Willebrand Disease Treatment Players Market Share
3.2.2 Top 10 Von Willebrand Disease Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Von Willebrand Disease Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Von Willebrand Disease Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Von Willebrand Disease Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Von Willebrand Disease Treatment Revenue Market Share by Application (2016-2021)
5.2 Von Willebrand Disease Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Von Willebrand Disease Treatment Revenue by Type (2016-2026)
6.2 North America Von Willebrand Disease Treatment Revenue by Application (2016-2026)
6.3 North America Von Willebrand Disease Treatment Market Size by Country
6.3.1 North America Von Willebrand Disease Treatment Revenue by Country (2016-2026)
6.3.2 United States Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Von Willebrand Disease Treatment Revenue by Type (2016-2026)
7.2 Europe Von Willebrand Disease Treatment Revenue by Application (2016-2026)
7.3 Europe Von Willebrand Disease Treatment Market Size by Country
7.3.1 Europe Von Willebrand Disease Treatment Revenue by Country (2016-2026)
7.3.2 Germany Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
7.3.3 France Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Von Willebrand Disease Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Von Willebrand Disease Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Von Willebrand Disease Treatment Market Size by Region
8.3.1 Asia-Pacific Von Willebrand Disease Treatment Revenue by Region (2016-2026)
8.3.2 China Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
8.3.5 India Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Von Willebrand Disease Treatment Revenue by Type (2016-2026)
9.2 South America Von Willebrand Disease Treatment Revenue by Application (2016-2026)
9.3 South America Von Willebrand Disease Treatment Market Size by Country
9.3.1 South America Von Willebrand Disease Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Von Willebrand Disease Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Von Willebrand Disease Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Von Willebrand Disease Treatment Market Size by Country
10.3.1 Middle East & Africa Von Willebrand Disease Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Von Willebrand Disease Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Von Willebrand Disease Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Von Willebrand Disease Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Von Willebrand Disease Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Von Willebrand Disease Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Von Willebrand Disease Treatment Revenue Market Share by Region (2021-2026)
Table 6. Takeda Corporate Information, Head Office, and Major Competitors
Table 7. Takeda Major Business
Table 8. Takeda Von Willebrand Disease Treatment Product and Solutions
Table 9. Takeda Von Willebrand Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. CSL Behring Corporate Information, Head Office, and Major Competitors
Table 11. CSL Behring Major Business
Table 12. CSL Behring Von Willebrand Disease Treatment Product and Solutions
Table 13. CSL Behring Von Willebrand Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Baxter Corporate Information, Head Office, and Major Competitors
Table 15. Baxter Major Business
Table 16. Baxter Von Willebrand Disease Treatment Product and Solutions
Table 17. Baxter Von Willebrand Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Grifols Corporate Information, Head Office, and Major Competitors
Table 19. Grifols Major Business
Table 20. Grifols Von Willebrand Disease Treatment Product and Solutions
Table 21. Grifols Von Willebrand Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Octapharma Corporate Information, Head Office, and Major Competitors
Table 23. Octapharma Major Business
Table 24. Octapharma Von Willebrand Disease Treatment Product and Solutions
Table 25. Octapharma Von Willebrand Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Von Willebrand Disease Treatment Revenue (USD Million) by Players (2019-2021)
Table 27. Global Von Willebrand Disease Treatment Revenue Share by Players (2019-2021)
Table 28. Breakdown of Von Willebrand Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Von Willebrand Disease Treatment Players Head Office, Products and Services Provided
Table 30. Von Willebrand Disease Treatment Mergers & Acquisitions in the Past Five Years
Table 31. Von Willebrand Disease Treatment New Entrants and Expansion Plans
Table 32. Global Von Willebrand Disease Treatment Revenue (USD Million) by Type (2016-2021)
Table 33. Global Von Willebrand Disease Treatment Revenue Share by Type (2016-2021)
Table 34. Global Von Willebrand Disease Treatment Revenue Forecast by Type (2021-2026)
Table 35. Global Von Willebrand Disease Treatment Revenue by Application (2016-2021)
Table 36. Global Von Willebrand Disease Treatment Revenue Forecast by Application (2021-2026)
Table 37. North America Von Willebrand Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Von Willebrand Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Von Willebrand Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Von Willebrand Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Von Willebrand Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Von Willebrand Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Von Willebrand Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Von Willebrand Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Von Willebrand Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Von Willebrand Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Von Willebrand Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Von Willebrand Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Von Willebrand Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Von Willebrand Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Von Willebrand Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Von Willebrand Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Von Willebrand Disease Treatment Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Von Willebrand Disease Treatment Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Von Willebrand Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Von Willebrand Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Von Willebrand Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Von Willebrand Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Von Willebrand Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Von Willebrand Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Von Willebrand Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Von Willebrand Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Von Willebrand Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Von Willebrand Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Von Willebrand Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Von Willebrand Disease Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Von Willebrand Disease Treatment Picture
Figure 2. Global Von Willebrand Disease Treatment Revenue Market Share by Type in 2020
Figure 3. Veyvondi
Figure 4. Humate-P
Figure 5. Alphanate
Figure 6. Others
Figure 7. Von Willebrand Disease Treatment Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Von Willebrand Disease Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Von Willebrand Disease Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Von Willebrand Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 14. Global Von Willebrand Disease Treatment Revenue Market Share by Region in 2020
Figure 15. North America Von Willebrand Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Von Willebrand Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Von Willebrand Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Von Willebrand Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Von Willebrand Disease Treatment Market Drivers
Figure 20. Von Willebrand Disease Treatment Market Restraints
Figure 21. Von Willebrand Disease Treatment Market Trends
Figure 22. Takeda Recent Developments and Future Plans
Figure 23. CSL Behring Recent Developments and Future Plans
Figure 24. Baxter Recent Developments and Future Plans
Figure 25. Grifols Recent Developments and Future Plans
Figure 26. Octapharma Recent Developments and Future Plans
Figure 28. Global Von Willebrand Disease Treatment Revenue Share by Players in 2020
Figure 29. Von Willebrand Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Von Willebrand Disease Treatment Revenue Market Share in 2020
Figure 31. Global Top 10 Players Von Willebrand Disease Treatment Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Von Willebrand Disease Treatment Revenue Share by Type in 2020
Figure 34. Global Von Willebrand Disease Treatment Market Share Forecast by Type (2021-2026)
Figure 35. Global Von Willebrand Disease Treatment Revenue Share by Application in 2020
Figure 36. Global Von Willebrand Disease Treatment Market Share Forecast by Application (2021-2026)
Figure 37. North America Von Willebrand Disease Treatment Sales Market Share by Type (2016-2026)
Figure 38. North America Von Willebrand Disease Treatment Sales Market Share by Application (2016-2026)
Figure 39. North America Von Willebrand Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 40. United States Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Von Willebrand Disease Treatment Sales Market Share by Type (2016-2026)
Figure 44. Europe Von Willebrand Disease Treatment Sales Market Share by Application (2016-2026)
Figure 45. Europe Von Willebrand Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 46. Germany Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Von Willebrand Disease Treatment Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Von Willebrand Disease Treatment Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Von Willebrand Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 54. China Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Von Willebrand Disease Treatment Sales Market Share by Type (2016-2026)
Figure 61. South America Von Willebrand Disease Treatment Sales Market Share by Application (2016-2026)
Figure 62. South America Von Willebrand Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Von Willebrand Disease Treatment Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Von Willebrand Disease Treatment Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Von Willebrand Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Von Willebrand Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
世界のフォンウィルブランド病（VWD）治療薬市場規模・現状・予測（2021年-2027年） Von Willebrand Disease is an inherited bleeding disorder that is caused by deficiency or dysfunction of Von Willebrand Factor (VWF). VWF is a plasma protein that mediates the initial adhesion of platelets at sites of vascular injury. This protein also binds to clotting factor VIII (FVIII) in the cir…- 世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年） Antihemophilic and von Willebrand factor complex is a combination medicine used to treat or prevent bleeding episodes in people with von Willebrand disease. Antihemophilic and von Willebrand factor complex is also used to treat or prevent bleeding episodes in people with hemophilia A. Market Analysi…
- 世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- 世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年） Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …
- 世界の髄膜炎菌性疾患治療市場 2021：企業別、地域別、種類・用途別 The Meningococcal Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…